Emily Fusco

With the likely further share shift in Chinese soybean imports from the US to Brazil, how is Corteva positioned for this?

Do you still expect North American health trends to improve starting in the back half of the year with a full recovery in 2027?

are we still on track for an update on this business with the Q4 earnings call in February? And also just a follow-up, have you begun to engage with private equity and strategics on this business?

what are your expectations for input inflation this year? And how should we expect net pricing to develop through the year